Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 44

1.

Comparative effectiveness of dabigatran, rivaroxaban, apixaban, and warfarin in the management of patients with nonvalvular atrial fibrillation.

Pink J, Pirmohamed M, Hughes DA.

Clin Pharmacol Ther. 2013 Aug;94(2):269-76. doi: 10.1038/clpt.2013.83. Epub 2013 Apr 25.

2.

An indirect comparison of dabigatran, rivaroxaban and apixaban for atrial fibrillation.

Mantha S, Ansell J.

Thromb Haemost. 2012 Sep;108(3):476-84. doi: 10.1160/TH12-02-0093. Epub 2012 Jun 28. Review.

PMID:
22740145
3.

Novel oral anticoagulants for stroke prevention in atrial fibrillation: focus on apixaban.

Potpara TS, Polovina MM, Licina MM, Stojanovic RM, Prostran MS, Lip GY.

Adv Ther. 2012 Jun;29(6):491-507. doi: 10.1007/s12325-012-0026-8. Epub 2012 Jun 7. Review.

PMID:
22684583
4.

Comparison of efficacy and safety of dabigatran, rivaroxaban and apixaban in patients with atrial fibrillation using network meta-analysis.

Harenberg J, Marx S, Diener HC, Lip GY, Marder VJ, Wehling M, Weiss C.

Int Angiol. 2012 Aug;31(4):330-9. Review.

PMID:
22801398
5.

Risk versus benefit of non-vitamin K dependent anticoagulants compared to warfarin for the management of atrial fibrillation in the elderly.

Ogbonna KC, Jeffery SM.

Drugs Aging. 2013 Jul;30(7):513-25. doi: 10.1007/s40266-013-0075-y. Review.

PMID:
23591934
6.

Dabigatran, ROCKET atrial fibrillation, and beyond: basic science, mechanisms of agents, monitoring, and reversal.

Bauer KA.

Stroke. 2013 Jun;44(6 Suppl 1):S38-40. doi: 10.1161/STROKEAHA.111.000387. Review. No abstract available.

7.

New alternative anticoagulants in atrial fibrillation: the move beyond warfarin.

Bhimani AA, Hong M.

Rev Recent Clin Trials. 2013 Jun;8(2):78-85. Review.

PMID:
23859143
8.

Novel oral anticoagulants for stroke prevention in patients with atrial fibrillation.

Berman JP, Halperin JL.

Hosp Pract (1995). 2013 Feb;41(1):37-48. doi: 10.3810/hp.2013.02.1006. Review.

PMID:
23466966
9.
10.

[Improvements in oral anticoagulant therapy for atrial fibrillation].

Briongos Figuero S, García Santos-Gallego C, Badimón JJ.

Med Clin (Barc). 2013 Dec 7;141(11):487-93. doi: 10.1016/j.medcli.2013.02.015. Epub 2013 Apr 16. Review. Spanish.

PMID:
23597953
11.

Non-vitamin K antagonist oral anticoagulants in cardiovascular disease management: evidence and unanswered questions.

Cheng JW, Barillari G.

J Clin Pharm Ther. 2014 Apr;39(2):118-35. doi: 10.1111/jcpt.12122. Epub 2014 Jan 3. Review.

PMID:
24383983
12.

Novel oral anticoagulants in secondary prevention of stroke.

Diener HC, Easton JD, Hankey GJ, Hart RG.

Best Pract Res Clin Haematol. 2013 Jun;26(2):131-9. doi: 10.1016/j.beha.2013.07.007. Epub 2013 Jul 30. Review.

PMID:
23953901
13.

Recommendations for the emergency management of complications associated with the new direct oral anticoagulants (DOACs), apixaban, dabigatran and rivaroxaban.

Steiner T, Böhm M, Dichgans M, Diener HC, Ell C, Endres M, Epple C, Grond M, Laufs U, Nickenig G, Riess H, Röther J, Schellinger PD, Spannagl M, Veltkamp R.

Clin Res Cardiol. 2013 Jun;102(6):399-412. doi: 10.1007/s00392-013-0560-7. Epub 2013 May 14. Review.

PMID:
23669868
14.

Meta-analysis of efficacy and safety of new oral anticoagulants (dabigatran, rivaroxaban, apixaban) versus warfarin in patients with atrial fibrillation.

Miller CS, Grandi SM, Shimony A, Filion KB, Eisenberg MJ.

Am J Cardiol. 2012 Aug 1;110(3):453-60. doi: 10.1016/j.amjcard.2012.03.049. Epub 2012 Apr 24. Review.

PMID:
22537354
15.

New anticoagulants (dabigatran, apixaban, rivaroxaban) for stroke prevention in atrial fibrillation.

Aguilar MI, Kuo RS, Freeman WD.

Neurol Clin. 2013 Aug;31(3):659-75. doi: 10.1016/j.ncl.2013.03.001. Review.

PMID:
23896498
16.

[Thromboembolic prophylaxis 2011: is warfarin on the wane?].

Di Pasquale G, Riva L.

G Ital Cardiol (Rome). 2011 Sep;12(9):556-65. doi: 10.1714/926.10169. Review. Italian.

PMID:
21892216
17.

A review of oral anticoagulants in patients with atrial fibrillation.

Greenspon AJ.

Postgrad Med. 2012 Nov;124(6):7-16. doi: 10.3810/pgm.2012.11.2608. Review.

PMID:
23322134
18.

[Update on current care guideline: atrial fibrillation].

Raatikainen P, Askonen K, Halinen M, Huikuri H, Koistinen J, Parikka H, Puurunen M, Virtanen V.

Duodecim. 2014;130(12):1194-6. Review. Finnish.

PMID:
25016666
19.

[New anticoagulants: dabigatran, rivaroxaban and apixaban].

Vargas Ruiz AG, Ramírez López AN, Medina Viramontes ME.

Gac Med Mex. 2012 May-Jun;148(3):257-64. Review. Spanish.

20.

Direct thrombin inhibitors and factor Xa inhibitors in patients with cerebrovascular disease.

Morales-Vidal S, Schneck MJ, Flaster M, Biller J.

Expert Rev Neurother. 2012 Feb;12(2):179-89; quiz 190. doi: 10.1586/ern.11.185. Review.

PMID:
22288673

Supplemental Content

Support Center